Moderna Shares Slump Amid Concerns About COVID-19 Vaccine Demand
- Investing News
admin
- 0
- 1 minute read
Moderna shares fell to an almost three-year low after the biotech firm reiterated its full-year guidance but warned it couldn’t yet predict COVID-19 vaccine demand.
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1909422439-a385ac4d36534f7d869d0aa4959d4e1b.jpg "An Overview of Annuities")
:max_bytes(150000):strip_icc():format(jpeg)/signing-6bd3c67514c149a3b78bda1b22e82d1e.jpg "Where to Get a Personal Loan Other Than a Bank")
:max_bytes(150000):strip_icc():format(jpeg)/madame-c-j-walker-5215655-v2-9e44b998ee69414d8c8d133844ac7f82.png "Who Was Madam C.J. Walker?")